Genmab Archives

genmab janssen blood cancer multiple myeloma

News and Trends 11 Jun 2019

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug Darzalex in certain types of blood cancer. Genmab will develop…

June 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Nov 2017

Welcome to the Blockbuster Club, Genmab!

Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of…

November 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European biotech was in the spotlight during this year's edition of…

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Now that we've got the bad news out of the way, we're here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.…

December 18, 2017 - 9 minutesmins - By Alex Dale

Best in Biotech 5 Dec 2017

Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017

Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with its year-end lists of the top things that happened this year. First up, the best…

December 5, 2017 - 6 minutesmins - By Evelyn Warner

News and Trends 26 Oct 2022

Scancell signs agreement with Genmab

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious disease, has signed a licensing agreement with Genmab, an international biotechnology company, to develop and…

October 26, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 3 Oct 2022

Oxford BioTherapeutics enters into antibody agreement with Genmab

Oxford BioTherapeutics (OBT) says Genmab has licensed a novel antibody related to one of OBT's IO programs. The target was discovered using Oxford BioTherapeutics' OGAP drug discovery platform, which incorporates…

October 3, 2022 - 2 minutesmins - By Jim Cornall

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Although biotech may seem like an industry that has only just gotten started, it was already up and running before the turn of the century. We took a look back…

January 23, 2018 - 10 minutesmins - By Alex Dale

News and Trends 1 Jul 2022

License submitted to FDA for drug to help those with large B-cell lymphoma

A biologics license application has been submitted to the US Food and Drug Administration (FDA) for an antibody to treat patients with B-cell lymphoma. Genmab A/S is a biotechnology company…

July 1, 2022 - 3 minutesmins - By Liza Laws

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European biotech is growing steadily and this year we welcome a…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

biotech stock price euronext genmab argenx

News and Trends 25 May 2021

Delayed IPOs and Market Drops Batter Biotech Stocks

Stock markets worldwide have experienced painful instability in the last few months. As a result, the European biotech market has seen stock prices falling and IPOs postponed. The Covid-19 pandemic…

May 25, 2021 - 6 minutesmins - By Jonathan Smith

multiple sclerosis novartis roche ema approval

News and Trends 27 Apr 2021

EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations centered mostly on improving existing approaches. Which areas of multiple sclerosis treatment need more options?…

April 27, 2021 - 6 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Partner with world-leading academics working on sustainable materials R&D

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering